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The Ratio of the Maximum High Attenuation Area
Dimension to the Maximum Tumor Dimension May Be an
Index of the Presence of Lymph Node Metastasis in Lung
Adenocarcinomas 3 cm or Smaller on High-Resolution
Computed Tomography
Ryota Nishio, MD,* Soichi Akata,* Kazuhiro Saito,* Tatsuo Ohira,* Masahiro Tsuboi,*
Takashi Hirano,* Norihiko Ikeda,* Fumio Kotake,‡ Harubumi Kato,† and Kimihiko Abe*
Background: Limited resection of the lung can improve the post-
operative quality of life if there is no lymph node metastasis. Small
adenocarcinomas frequently appear on radiographs with areas of
ground glass attenuation. We examined whether there is a correla-
tion between the presence of lymph node metastasis and the ratio of
the intratumor high-attenuation area (greatest dimension of high-
attenuation area [H] to the maximum tumor dimension [T], H/T
ratio) on high-resolution computed tomography (HRCT).
Methods: From January 1996 to June 2004, we studied 281 patients
with lung adenocarcinomas of 3 cm or less in maximum dimension
on preoperative HRCT. Each of the 281 patients had a lobectomy
and lymph node dissection, and there was no case of limited
resection.
Results: Lymph node metastasis was present in 11.4% (32 of 281
cases, N1  13 cases, N2  19 cases). None of the 94 cases with an
H/T ratio of 60% or less had lymph node metastasis. Moreover,
lymph node metastasis was noted even in a 6-mm tumor when the
H/T ratio was 100%. Of the 187 cases with tumors having an H/T
ratio greater than 60%, 32 had lymph node metastasis.
Conclusions: The relationship between the H/T ratio and lymph
node metastases was evaluated by HRCT in lung adenocarcinomas
3 cm or smaller in maximum dimension. The H/T ratio may provide
useful information in deciding on limited resection for lung cancer
in such cases.
KeyWords: Lung cancer, Adenocarcinoma, High-resolution com-
puted tomography, Ground-glass attenuation.
(J Thorac Oncol. 2007;2: 29–33)
The current standard surgical procedure for lung cancer islobectomy with lymphadenectomy. However, according
to Noguchi et al.,1 lymph node metastasis does not occur in
lung adenocarcinoma type A or B according to his classifi-
cation, and the postoperative 5-year survival rate is 100%.
The next step is to reduce the extent of resection and improve
the postoperative quality of life (QOL), but for this to be
achieved, the absence of lymph node metastases is an essen-
tial premise.2,3 In recent years, high-resolution computed
tomography (HRCT) has been useful in identifying the indi-
cations of limited resection for lung cancer.3–6 Ikeda et al.4
reported that when the proportion of the high-attenuation area
was 50% or less in lung adenocarcinomas 2 cm or smaller,
Noguchi type A and B adenocarcinomas of the lung ac-
counted for 76% of all cases. It is generally considered that
adenocarcinomas less than 3 cm in maximum dimension are
unlikely to have lymph node metastases, but even in such
cases, some patients and surgeons do not feel comfortable
with the idea of performing limited resection due to lack of
supporting evidence. We therefore examined the relationship
between the presence or absence of lymph node metastasis,
as demonstrated pathologically, and the ratio of the max-
imum dimension of the intratumor high-attenuation area to
the maximum dimension of the tumor (H/T ratio)6,7 to
determine whether this index could be used to select cases
in which limited resection is indicated, based on HRCT
findings.
PATIENTS AND METHODS
The retrospectively investigated subjects were 281 con-
secutive patients who underwent preoperative HRCT followed
by subsequent resection and hilar and mediastinal lymphadenec-
tomy at our hospital between January 1996 and June 2004 and
who were found to have lung adenocarcinomas 3 cm or less in
maximum dimension on the resected specimen.
The CT instruments that we used were Hi-Speed Ad-
vantage (GE Medical Systems, Milwaukee, WI), Light-Speed
Ultra (GE Medical Systems), ProSeed-SA (Yokogawa Med-
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ical Systems, Tokyo, Japan), and Sfida (Shimadzu Medical
Systems, Kyoto, Japan). For HRCT, images were acquired
under the following conditions in all patients: 1- to 3-mm
slice intervals at 1-mm slice thickness; the field of view was
20 cm; bone algorithm; window width was 1500 to 1800; and
window level was 500 to 700. The ratio of the maximum
dimension of the intratumor high-attenuation area (H) to the
maximum dimension of the tumor (T) (H/T ratio) was calcu-
lated (Figure 1). Each of the 281 patients had a lobectomy
and lymph node dissection, and there was no case of limited
resection. We measured with a ruler on x-ray film the length
of the greatest dimension of the tumor and the greatest
dimension of the area of high attenuation. The correlation
between the H/T ratio and the N factor was evaluated by two
radiologists who reached a consensus. The radiologists were
blinded to the clinical information. Because this was a retro-
spective study informed consent was not considered neces-
sary, and the study was approved by the Institutional Review
Board Committee of our institution.
RESULTS
All 281 consecutive patients from January 1996 to June
2004 were included in this study. There were 132 men aged 42
to 82 years (mean, 64.5 years) and 149 women aged 31 to 82
years (mean, 5.5 years). Tumor sizes ranged from 5 to 30 mm
(mean,19.0 mm).
Lymph node metastasis was present in 11.4% overall
(32 of 281 cases, N1  13 cases, N2  19 cases) (Table 1).
The 60% cutoff figure was established based on our data. The
smallest H/T ratio in a case with nodal metastasis was 65.5%;
therefore, we chose 60% as providing an almost 10% safety
margin. No lymph node metastasis was present in cases
with an H/T ratio of 60% or less (94 of 281 cases; 33.5%
overall) (Figures 2 and 3). In contrast, an H/T ratio
FIGURE 1. Measurement of tumor dimension and high-
attenuation area. H/T ratio, ratio of the maximum dimension
of the intratumor high-attenuation area (H) to the maximum
dimension of the tumor (T).
TABLE 1. The Relationship Between the High Attenuation Area to the Maximum Dimension of the Tumor and H/T Ratio and
Lymph Node Metastases
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exceeding 60% was seen in 66.5% of cases (187 of 281
cases), and lymph node metastases was recognized in
17.1% of those cases (32 of 187 cases) (Figures 4, 5, and 6).
Moreover, lymph node metastasis was noted even in cases
with a tumor size of only 6 mm, in which the H/T ratio was
100% (Figure 6).
FIGURE 2. Case 1. True negative: An 81-year-old woman.
High-resolution computed tomography scan of the right upper
lobe shows a nodule with a maximum dimension of 19 mm
with no high-attenuation area (H/T ratio  0%). The absence of
lymph node metastasis (N0) was confirmed pathologically. H/T
ratio, ratio of the maximum dimension of the intratumor high-
attenuation area (H) to the maximum dimension of the tumor (T).
FIGURE 3. Case 2. True negative: A 73-year-old woman.
High-resolution computed tomography scan of the right up-
per lobe shows a nodule with a maximum dimension of 26
mm and a 15-mm high-attenuation area (H/T ratio 
57.6%). The absence of lymph node metastasis (N0) was
confirmed pathologically. H/T ratio, ratio of the maximum
dimension of the intratumor high-attenuation area (H) to
the maximum dimension of the tumor (T).
FIGURE 4. Case 3. True positive: A 62-year-old man. High-
resolution computed tomography scan of the left upper lobe
shows a nodule with a maximum dimension of 16 mm and
a 15-mm high-attenuation area (H/T ratio  93.8%). Ipsilat-
eral hilar lymph node metastases (N1) were confirmed
pathologically. H/T ratio, ratio of the maximum dimension
of the intratumor high-attenuation area (H) to the maximum
dimension of the tumor (T).
FIGURE 5. Case 4. False positive: A 52-year-old man. High-
resolution computed tomography scan of the right upper
lobe shows a nodule with a maximum dimension of 24 mm
and a 17-mm high-attenuation area (H/T ratio  70.3%).
The H/T ratio exceeded 60%, but there was no lymph node
metastasis (N0). H/T ratio, ratio of the maximum dimension
of the intratumor high-attenuation area (H) to the maximum
dimension of the tumor (T).
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The accuracy of diagnosis of lymph node metastases
was 0.443, and sensitivity and specificity were, respectively,
1.0 and 0.378, whereas positive and negative predictive
values were, respectively, 0.171 and 1.0 (Table 2).
DISCUSSION
In general, lobectomy with systematic lymph node
dissection is now recommended as the standard treatment for
lung cancer.4 However, there are cases in which lymph node
metastasis is discovered only on postoperative pathologic
evaluation4,5; thus, although nodule volume measurements on
short-term repeated CT examination can provide some indi-
cation of malignant growth, we cannot completely rely only
on the size of the hilar or mediastinal lymph nodes on CT.
Other methods to evaluate the probability of lymph node
metastasis are therefore necessary. Although studies employ-
ing quantitative contrast-enhanced CT techniques to distin-
guish between benign and malignant small lesions have been
reported, the appropriateness of applying these methods to
indicate the probability of lymph node metastasis appears, at
best, limited.8
The Noguchi classification is well-known to reflect the
prognosis of small adenocarcinomas of the lung,1 and type A
is defined as localized bronchioalveolar carcinoma
(LBAC), type B as LBAC with foci of collapse of alveolar
structures, type C as LBAC with foci of active fibroblastic
proliferation, type D as poorly differentiated adenocarci-
noma, type E as tubular adenocarcinoma, and type F as
papillary adenocarcinoma with compressive and destruc-
tive growth. Because the incidence of lymph node metas-
tasis was 0% and the postoperative 5-year survival rate
was 100% in Noguchi types A and B,9 this classification is
useful for consideration of limited resection. To analyze
the correlation between lymph node metastasis and Nogu-
chi classification, Shinada et al.3 evaluated 50 cases of
adenocarcinomas of 2 cm or less and reported that Noguchi
types A and B showed no lymph node metastases in 19
cases, but type C showed lymph node metastases in seven
of 25 cases (28%), types D, E, and F showed lymph node
metastases in three of six cases (50%). Because these data
were based on the Noguchi classification, they are not
applicable for 2- to 3-cm tumors. Moreover, because the
Noguchi classification can only be made based on patho-
logic examination of the resected specimen, we need a
method that allows accurate evaluation of lymph node
metastasis by preoperative CT scan findings. Ikeda et al.4
reported the correlation between the absence of lymph
node metastases and ground glass opacity (GGO). In their
study, patients with a GGO ratio (the ratio of the intratu-
mor high-attenuation area in the GGO) less than 50% of
the total tumor had no lymph node metastases. However,
lymph node metastasis was seen in patients with a GGO
ratio of 50% or more. Furthermore, Tsuchida et al.2 re-
ported that no lymph node metastasis was noted in the
excised specimens in any of 50 cases of lung adenocarci-
nomas 2 cm or less in maximum dimension with a GGO
ratio of 50% or less.7 Using HRCT, we investigated the
relationship between the H/T ratio and lymph node metas-
tases in 281 consecutively surgical cases of lung adeno-
carcinoma with a diameter of 3 cm or less. In our results,
no lymph node metastasis was seen in tumors with an H/T
ratio of 65.5% or less (94 of 281 cases: 33.5%) (Figs. 3 and
4). Taking a 10% safety margin into consideration for this
result, we set the cutoff rate at 60%. This is very important
when considering performing limited resection. Matsu-
guma et al.5 classified 96 cases of 3 cm or smaller lung
adenocarcinomas into five categories based on the ratio of
GGO (GGO ratio [the ratio of the GGO in the maximum
dimension]: 0%, group I; 1% to 25%, group II; 26% to
50%, group III; 51% to 75%, group IV; and 76 –100%,
group V) and evaluated the N classification based on these
categories. Lymph node metastasis was present in 0% in
groups III, IV, and V; in 18% in group II; and 31% in
group I, showing that the incidence of lymph node metas-
tases ratio increased with a decrease in the GGO ratio,
suggesting a correlation between the GGO ratio and lymph
FIGURE 6. Case 5. True positive: A 71-year-old man. High-
resolution computed tomography scan of the right upper
lobe shows a nodule with a maximum dimension of 6 mm
and a 6-mm high-attenuation area (H/T ratio  100%).
Even though it was a small tumor of only 6 mm, ipsilateral
hilar lymph node metastasis metastases (N1) were confirmed
pathologically. H/T ratio, ratio of the maximum dimension
of the intratumor high-attenuation area (H) to the maximum
dimension of the tumor (T).
TABLE 2. Results of Diagnosis of Lymph Node Metastases
by H/T Ratio
Accuracy 0.443
Sensitivity 1
Specificity 0.378
Positive predictive value 0.171
Negative predictive value 1
H/T ratio, ratio of the maximum dimension of the intratumor high-attenuation area
(H) to the maximum dimension of the tumor (T).
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node metastasis. Although they only had 96 cases, their
results do not contradict ours. In our study, lymph node
metastasis was noted even in tumors of only 6 mm when
the H/T ratio was 100%, and the survival is poor. There-
fore, in tumors with an H/T ratio of 100% (i.e., the entire
shadow is an area of high attenuation), limited resection is
not indicated, regardless of how small the primary lesion
may be.
Using these criteria, the false-negative (i.e., cases with
an H/T ratio of 60% or less with metastasis) rate was 0%,
whereas the false-positive (i.e., H/T ratio of 60% or more but
with no metastasis) rate was high. When an H/T ratio of 60%
or lower was set as the cutoff value for the indications of
limited resection, this did not identify all cases in which
lymph node metastasis was absent; thus, unnecessary lobec-
tomies were included in some cases (55%; 155 of 281 cases).
In the study reported by Matsuguma et al.,5 lymph node
metastasis was present in only 25.7% of cases with an
intratumor GGO ratio of 50% or lower.
The studies of Matsuguma et al. employed a completely
different system using large percentage bands (e.g., GGO
ratio: 0%, group I; 1% to 25%, group II; 26% to 50%, group
III; 51% to 75%, group IV; and group V, 76% to 100%),
which we thought was less accurate than an exact numerical
ratio such as the H/T ratio. We therefore sought to determine
whether the same absence of lymph node metastasis could be
determined in cases meeting the TNM classification of T1,
that is, adenocarcinomas 3 cm or less in largest dimension,
which would allow unnecessary lung and lymph node resec-
tion to be avoided.
It is therefore necessary to try further determine the
cases of tumors with an H/T ratio exceeding 60% but without
metastasis. We are planning to perform three-dimensional
evaluation of tumor diameter and high-attenuation areas in
the hope of establishing even more accurate parameters that
will contribute to better patient care.
CONCLUSION
The relationship between the H/T ratio and lymph node
metastases was evaluated by HRCT in lung adenocarcinomas
3 cm or smaller in maximum dimension. The H/T ratio may
provide useful information in deciding on limited resection
for lung cancer in such cases.
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